NCT01797523 · OUTCOME

Number of Mutations Detected in Women With Endometrial Cancer

A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma · Source last updated 2026-07-30

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: MEDIAN
Unit: mutations detected
Interval / dispersion: Full Range
Time frame: 93 months

Analysis population: There were 9 patients who had mutational analysis on their primary tumor in addition to the research biopsy performed as part of the study.

Groups in this outcome

Rad-Let-Met

Everolimus 10 mg PO daily + Letrozole 2.5 mg PO daily + Metformin 500 mg PO twice daily on a 4 week schedule

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Rad-Let-Met	62

Reported measurements

Source class 1

Values in mutations detected · Interval/dispersion: Full Range
Group	Value	Spread	Lower	Upper	Comment
Rad-Let-Met	2	Not reported	1	4	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
lower Limit
1
upper Limit
4
value
2

denoms

counts
group Id
OG000
value
62
units
Participants

dispersion Type

Full Range

groups

description
Everolimus 10 mg PO daily + Letrozole 2.5 mg PO daily + Metformin 500 mg PO twice daily on a 4 week schedule
id
OG000
title
Rad-Let-Met

param Type

MEDIAN

population Description

There were 9 patients who had mutational analysis on their primary tumor in addition to the research biopsy performed as part of the study.

reporting Status

POSTED

time Frame

93 months

title

Number of Mutations Detected in Women With Endometrial Cancer

type

SECONDARY

unit Of Measure

mutations detected

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Independent clinical review pending · Not medical advice